Catatonia following abrupt stoppage of clozapine

Australian and New Zealand Journal of Psychiatry

Volumn 45, Issue 6, 2011, Pages 499-

  Kumar, Sudhir ^a   Sur, Shravani ^a   Singh, Ashutosh ^a  

^a Institute of Mental Health and Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; LORAZEPAM; RISPERIDONE;

ADULT; ANAMNESIS; BODY POSTURE; CASE REPORT; CATATONIA; DEFENSE MECHANISM; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEVER; HUMAN; LETTER; LEUKOPENIA; MALE; MUSCLE RIGIDITY; MUTISM; NEUROLEPTIC MALIGNANT SYNDROME; NEUTROPHIL COUNT; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; CATATONIA; CLOZAPINE; HUMANS; MALE; SCHIZOPHRENIA; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 79955961173     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.3109/00048674.2011.564135     Document Type: Letter

References (5)

1. de Leon J, Stanilla JK, White AO, Simpson GM. Anticholinergics to treat clozapine withdrawal. Letter. J Clin Psychiatry 1994; 55:319.
2. Bastiampillai T, Forooziya F, Dhillon R. Clozapine-withdrawal catatonia. Correspondence. Aust N Z J Psychiatry 2009; 43:283-285.
3. Moncrieff J. Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem. Med Hypotheses 2006; 67:517-523. (Pubitemid 44202375)
4. Lee JWY, Robertson S. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report. Ann Clin Psychiatry 1997; 9:165-169. (Pubitemid 27470388)
5. Yeh AW, Lee JW, Cheng TC, Wen JK, Chen WH. Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a case report. Clin Neuropharmacol 2004; 27:216-218. (Pubitemid 39447217)